Park Sujin, Dong Bin, Matsumura Fumio
Department of Environmental Toxicology, University of California, 1 Shields Avenue, Davis, California 95616, USA.
Biochemistry. 2007 Jan 23;46(3):899-908. doi: 10.1021/bi061925f.
We investigated the mechanism by which activation of the Ah receptor by dioxin (TCDD) was accompanied by rapid activation of c-Src kinase activity. A Western blotting analysis showed that such action of TCDD in MCF10A cells could effectively be suppressed by treatment with a specific inhibitor of Src family kinase, PP-2, as judged by Western blot detection of the active form of Src protein, indicating that Src kinase is directly activated by TCDD. Such an event, occurring within 10-30 min of the addition of TCDD, is also accompanied by simultaneous translocation of both Src and cdc37 proteins from cytosol into the 100,000 x g membrane fraction containing the plasma membrane. By dissociating the cytosolic Src-cdc37-HSP90 complex with 17 nM geldanamycin, an optimum concentration for affecting this cytosolic cdc37 complex, but not the cytosolic Ah receptor complex, we could show that the action of TCDD in activating c-Src and cdc37 was abolished, but not its action on CYP1A1. The important role of cdc37 in the action of TCDD-induced activation of c-Src was also confirmed by blocking cdc37 gene translation with the antisense oligonucleotide treatment as well as the siRNA preparation designed to silence cdc37 expression. To understand the functional meaning of the disruption of the Src-cdc37-HSP90 complex by 17 nM geldanamycin at the cellular level, we investigated its effect on TCDD-induced anti-apoptotic action. The results showed that geldanamycin at this concentration could also abolish this cellular effect of TCDD. Interestingly, such a role of cdc37 in mediating the action of TCDD appears to be limited to activation of c-Src kinase, but not kinases associated with activation of NFkB, C/EBPalpha, or ERK. Together, these observations support the hypothesis that there is a specific coordination between the activation of the cytosolic Ah receptor and the c-Src- and cdc37-containing HSP90 complex.
我们研究了二噁英(TCDD)激活芳烃受体(Ah受体)时伴随c-Src激酶活性快速激活的机制。蛋白质免疫印迹分析表明,通过蛋白质免疫印迹检测Src蛋白的活性形式判断,用Src家族激酶的特异性抑制剂PP-2处理可有效抑制TCDD在MCF10A细胞中的这种作用,这表明Src激酶被TCDD直接激活。在添加TCDD后10 - 30分钟内发生的这一事件,还伴随着Src和cdc37蛋白同时从胞质溶胶转位到含有质膜的100,000×g膜组分中。通过用17 nM格尔德霉素解离胞质溶胶中的Src-cdc37-HSP90复合物(影响该胞质溶胶cdc37复合物的最佳浓度,但不影响胞质溶胶Ah受体复合物),我们可以表明TCDD激活c-Src和cdc37的作用被消除,但对CYP1A1的作用未被消除。用反义寡核苷酸处理以及设计用于沉默cdc37表达的小干扰RNA(siRNA)制剂阻断cdc37基因翻译,也证实了cdc37在TCDD诱导的c-Src激活作用中的重要作用。为了在细胞水平上理解17 nM格尔德霉素破坏Src-cdc37-HSP90复合物的功能意义,我们研究了其对TCDD诱导的抗凋亡作用的影响。结果表明,该浓度的格尔德霉素也可消除TCDD的这种细胞效应。有趣的是,cdc37在介导TCDD作用中的这种作用似乎仅限于激活c-Src激酶,而不涉及与NFkB、C/EBPα或ERK激活相关的激酶。总之,这些观察结果支持这样的假设,即胞质溶胶Ah受体的激活与含有c-Src和cdc37的HSP90复合物之间存在特定的协同作用。